Patients

PATIENTS

Patients Like You are at the Center of All We Do

At Alnylam, we want to understand your journey, your experiences, and your unique needs. You inspire us to learn as much as we can, to persevere and continue to advance the development of potential therapies to treat a broad range of both rare and more prevalent diseases. We take pride in working together to achieve mutual goals such as increasing awareness, enabling diagnosis, and providing education and services to support patient communities. This kind of partnership has allowed Alnylam to pioneer RNAi therapeutics, and development of innovative new medicines for patients worldwide.

We have a dedicated team to ensure your perspectives are represented at Alnylam. If you are an advocate interested in engaging with us, we want to hear from you and invite you to learn more about Patient Advocacy at Alnylam.

Learn about RNAi and our investigational therapies

About RNAi Therapeutics and How They Work

RNAi therapeutics are a type of gene-silencing medicine invented by Alnylam scientists that is based on RNA interference (RNAi). The discovery of RNAi was awarded the Nobel Prize in Physiology or Medicine in 2006.

Access To Investigational Medicines

Alnylam is dedicated to developing new therapies that have a positive impact on patient health, and to serving patients, patient families and patient communities through education, empathy, and awareness. We understand that there are seriously ill patients who will not be eligible for our clinical trials and may not have options for alternative therapies, including investigational therapies in trials being conducted by other sponsors. In these circumstances, Alnylam will consider providing a requesting physician with pre-approval access to a specific Alnylam investigational medicine, for the treatment of an individual patient outside of a clinical trial, when certain conditions are met.

Learn More ›

Patient Focus

VISIT THE NEWSROOM ›

PATIENTS

Patients Like You are at the Center of All We Do

About RNAi Therapeutics and How They Work

Access To Investigational Medicines

Patient Focus

FOLLOW US